跳至主要内容
临床试验/NCT02742064
NCT02742064已完成不适用

Quantified Mobile Sensing for Improving Diagnosis and Measuring Disease Progression

Cogito Health Inc1 个研究点 分布在 1 个国家目标入组 899 人开始时间: 2015年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
899
试验地点
1
主要终点
Severity of Mania symptoms as assessed by ASRM

研究概览

简要总结

The purpose of this study is to determine if a mobile sensing platform can passively and objectively detect the presence of clinically significant mood disorder symptomatology and symptom progression over time. Meeting this goal will allow for improved risk categorization, prediction of relapse, and measurement of disease progression in a lifetime prevalence population.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 or older
  • Have a smartphone and cell service plan, including voice and data, that meets the device requirements of the Mobile Sensing Platform.
  • Enrolled in the MoodNetwork

排除标准

  • Report positively on the QIDS-SR suicide item during study intake
  • Total score greater than 15 on the QIDS-SR during the screening process

结局指标

主要结局

Severity of Mania symptoms as assessed by ASRM

时间窗: 6 months

Severity of MDD symptoms as assessed by QIDS SR

时间窗: 6 months

次要结局

未报告次要终点

研究者

发起方
Cogito Health Inc
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Quantified Mobile Sensing for Improving Diagnosis... | 临床试验